Overhauls

• Santander is overhauling its Asia-Pacific operations as part of a broader regional refocus and cost-cutting strategy. • The Spanish banking giant has replaced its top banker in Beijing and introduced stricter oversight mechanisms to manage regional activities. • This restructuring aims to optimize operational efficiency and tighten risk management across its Asian business units.

Social housing landlords to be able to evict perpetrators, while right-to-buy tenancy requirements to riseSocial housing landlords will be able to evict domestic abuse perpetrators under a new bill, which will also increase the tenancy required before residents qualify for the right-to-buy scheme from three to 10 years in England.The government said the bill, which will be debated in the House of Lords on Monday, would fix “the long-term decline in social housing” and offer new protections for social tenants who were subjected to domestic abuse. Continue reading...

• The first Nobel award ceremony since President Trump overhauled the board of trustees earlier this year is set to proceed with new appointees influencing selections. • Changes aim to align prizes with American priorities, sparking international debate on politicization. • Shift matters for U.S. soft power and could alter future laureate choices in peace and economics.

• The Kennedy Center will hold its first award ceremony since President Trump overhauled the board of trustees earlier this year. • Changes aim to align cultural programming with administration priorities. • The event draws attention to federal arts funding debates and political influence on institutions.

• Trump 2.0 policies terminated or overhauled HHS advisory committees, including ACIP with all members replaced in January 2026 by RFK Jr., leading to weakened hepatitis B and COVID-19 vaccine recommendations. • NIH advisory councils have not met, with the director's committee disbanded for over a year; USPSTF has not met since March 2025. • Senator Murray criticized leadership for prohibiting NIH grant processes; new ACIP includes controversial figures like an Alzheimer's patient from the withdrawn aducanumab trial.